Cardiovascular consequences of obstructive sleep apnea syndrome;Conséquences cardiovasculaires du syndrome d'apnées obstructives du sommeil

Revue de Medecine Interne

Volumn 24, Issue 8, 2003, Pages 530-537

  Baguet, J P ^a   Pepin J L ^a   Hammer, L ^a   Levy P ^a   Mallion, J M ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cardiovascular disorders; Hypertension; Obstructive sleep apnea syndrome; Sympathetic activation

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; DISEASE ASSOCIATION; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; HYPERACTIVITY; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PROGNOSIS; PULMONARY HYPERTENSION; SLEEP APNEA SYNDROME;

EID: 0043173913     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(03)00142-5     Document Type: Article

References (50)

1. Kiely JL, McNicholas WT. Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Resp J 2000;16:128-33.
2. Pépin JL, Lévy P. Physiopathologie du risque cardiovasculaire au cours du syndrome d'apnées du sommeil. Rev Neurol 2002;158:785-97.
3. Young T, Peppard P, Gottlieb D. The epidemiology of obstructive sleep apnoea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217-39.
4. Lévy P, Pépin JL. Syndrome d'apnées du sommeil et affections cardiovasculaires: le SAOS est il un facteur de risque? In: Weitzenblum E, Racineux JL, editors. Syndrome d'apnées obstructives du sommeil. Paris: Masson; 1999. p. 125-46.
5. He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 1988;94:9-14.
6. Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest 1988;94:1200-4.
7. Smith R, Veale D, Pepin JL, Levy P. Autonomic nervous system and obstructive sleep apneas. Rev Mal Respir 1999;16:287-304.
8. Koskenvuo M, Kaprio J, Partinen D, Langinvainio H, Sarna S, Heikkilä K. Snoring as a risk factor for hypertension and angina pectoris. Lancet 1985;ii:893-6.
9. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al., the Sleep Heart Health Study. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000;283:1829-36.
10. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. Br Med J 2000;320:479-82.
11. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84.
12. Hla KM, Young TB, Bidwell T, Palta M, Skatrud JB, Dempsey J. Sleep apnea and hypertension. A population-based study. Ann Intern Med 1994;120:382-8.
13. Sjöström C, Lindberg E, Elmasry A, Hägg A, Svärdsudd K, Janson C. Prevalence of sleep apnoea and snoring in hypertensive men: a population based study. Thorax 2002;57:602-7.
14. Grote L, Hedner J, Peter JH. Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens 2000;18:679-85.
15. Grote L, Hedner J, Peter JH. Mean blood pressure, pulse pressure and grade of hypertension in untreated hypertensive patients with sleep-related breathing disorder. J Hypertens 2001;19:683-90.
16. Portaluppi F, Provini F, Cortelli P, Plazzi G, Bertozzi N, Manfredini R, et al. Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension. J Hypertens 1997;15:1227-33.
17. Loredo JS, Ancoli-Israel S, Dimsdale JE. Sleep quality and blood pressure dipping in obstructive sleep apnea. Am J Hypertens 2001;14:887-92.
18. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure. A placebo trial. Hypertension 2000;35:144-7.
19. Sanner BM, Tepel M, Markmann A, Zidek W. Effect of continuous positive airway pressure therapy on 24-hour blood pressure in patients with obstructive sleep apnea syndrome. Am J Hypertens 2002;15:251-7.
20. Hla KM, Skatrud JB, Finn L, Palta M, Young T. The effect of correction of sleep-disordered breathing on BP in untreated hypertension. Chest 2002;122:1125-32.
21. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002;359:204-10.
22. Faccenda JF, Mackay TW, Boon NA, Douglas NJ. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001;163:344-8.
23. Ziegler MG, Mills PJ, Loredo JS, Ancoli-Israel S, Dimsdale JE. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest 2001;120:887-93.
24. Kraiczi H, Hedner J, Peker Y, Grote L. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000;161:1423-8.
25. Peker Y, Kraiczi H, Hedner J, Löth S, Johansson A, Bende M. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 1999;13:179-84.
26. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25.
27. Young T, Peppard P. Sleep-disordered breathing and cardiovascular disease: epidemiologic evidence for a relationship. Sleep 2000;23(Suppl 4):S122-6.
28. Peled N, Abinader EG, Pillar G, Sharif D, Lavie P. Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease. J Am Coll Cardiol 1999;34:1744-9.
29. Mooe T, Rabben T, Wiklund U, Franklin KA, Eriksson P. Sleep-disordered breathing in men with coronary artery disease. Chest 1996;109:659-63.
30. Schäfer H, Koehler U, Ewig S, Hasper E, Tasci S, Lüderitz B. Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 1999;92:79-84.
31. Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet 1990;336:261-4.
32. Wright J, Johns R, Watt I, Melville A, Sheldon T. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. Br Med J 1997;314:851-60.
33. Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 1998;97:2154-9.
34. Malone S, Liu PP, Holloway R, Rutherford R, Xie A, Bradley TD. Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 1991;338:1480-4.
35. Hanly PJ, Zuberi-Khokhar NS. Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 1996;153:272-6.
36. Garrigue S, Bordier P, Jais P, Shah DC, Hocini M, Raherisson C, et al. Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med 2002;346:404-12.
37. Hedner J, Ejnell H, Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens 1990;8:941-6.
38. Kraiczi H, Peker Y, Caidahl K, Samuelsson A, Hedner J. Blood pressure, cardiac structure and severity of obstructive sleep apnea in a sleep clinic population. J Hypertens 2001;19:2071-8.
39. Noda A, Okada T, Yasuma F, Nakashima N, Yokota M. Cardiac hypertrophy in obstructive sleep apnea syndrome. Chest 1995;107:1538-44.
40. Davies RJO, Crosby J, Prothero A, Stradling JR. Ambulatory blood pressure and left ventricular hypertrophy in subjects with untreated obstructive sleep apnoea and snoring, compared with matched control subjects, and their response to treatment. Clin Sci 1994;86:417-24.
41. Guilleminault C, Connoly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983;52:490-4.
42. Javaheri S. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 2000;101:392-7.
43. Miller WP. Cardiac arrhythmias and conduction disturbances in the sleep apnea syndrome. Prevalence and significance. Am J Med 1982;73:317-21.
44. Koehler U, Fus E, Grimm W, Pankow W, Schäfer H, Stammnitz A, et al. Heart block in patients with obstructive sleep apnoea: pathogenetic factors and effects of treatment. Eur Respir J 1998;11:434-9.
45. Palomaki H. Snoring and the risk of ischemic brain infarction. Stroke 1991;22:1021-5.
46. Hermann DM, Bassetti CL. Sleep-disordered breathing and stroke. Curr Opin Neurol 2003;16:87-90.
47. Parra O, Arboix A, Bechich S, Garcia-Eroles L, Montserrat JM, Lopez JA, et al. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000;161:375-80.
48. Wessendorf TE, Teschler H, Wang YM, Konietzko N, Thilmann AF. Sleep-disordered breathing among patients with first-ever stroke. J Neurol 2000;247:41-7.
49. Bassetti C, Aldrich MS. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep 1999;22:217-23.
50. Mohsenin V. Sleep-related breathing disorders and risk of stroke. Stroke 2001;32:1271-8.